Business Description
Mizuho Medy Co Ltd
ISIN : JP3885900005
Description
Mizuho Medy Co Ltd engages in research and development, manufacture and distribution of in-vitro diagnostic products. The company provides immuno assay test products, such as influenza virus kits; Infectious diseases test kits; fecal occult blood test kits for detection of human hemoglobin and human transferrin in feces; and biochemical liquid stable reagents for professionals. It also offers HCG (midstream test), including digital p-check test for OTC. It also offers fruit tree virus test drugs to agricultural testing places.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.83 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 9.49 | |||||
| Beneish M-Score | -2.65 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 37.8 | |||||
| 3-Year EBITDA Growth Rate | 106.2 | |||||
| 3-Year EPS without NRI Growth Rate | 131 | |||||
| 3-Year FCF Growth Rate | 165.7 | |||||
| 3-Year Book Growth Rate | 60.6 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.12 | |||||
| 9-Day RSI | 46.43 | |||||
| 14-Day RSI | 44.67 | |||||
| 6-1 Month Momentum % | 6.11 | |||||
| 12-1 Month Momentum % | 66.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.19 | |||||
| Quick Ratio | 6.41 | |||||
| Cash Ratio | 4.46 | |||||
| Days Inventory | 188.75 | |||||
| Days Sales Outstanding | 104.41 | |||||
| Days Payable | 44.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.82 | |||||
| Dividend Payout Ratio | 0.29 | |||||
| 3-Year Dividend Growth Rate | 128.9 | |||||
| Forward Dividend Yield % | 4.82 | |||||
| 5-Year Yield-on-Cost % | 50.06 | |||||
| Shareholder Yield % | 4.82 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 73.42 | |||||
| Operating Margin % | 47.42 | |||||
| Net Margin % | 35.26 | |||||
| FCF Margin % | 32.82 | |||||
| ROE % | 27.43 | |||||
| ROA % | 22.66 | |||||
| ROIC % | 53.98 | |||||
| ROC (Joel Greenblatt) % | 95.59 | |||||
| ROCE % | 34.59 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 7.91 | |||||
| PE Ratio without NRI | 7.91 | |||||
| Shiller PE Ratio | 15.04 | |||||
| Price-to-Owner-Earnings | 6.32 | |||||
| PEG Ratio | 0.14 | |||||
| PS Ratio | 2.79 | |||||
| PB Ratio | 2.07 | |||||
| Price-to-Tangible-Book | 2.07 | |||||
| Price-to-Free-Cash-Flow | 8.5 | |||||
| Price-to-Operating-Cash-Flow | 7.93 | |||||
| EV-to-EBIT | 4.06 | |||||
| EV-to-EBITDA | 4.06 | |||||
| EV-to-Revenue | 1.93 | |||||
| EV-to-FCF | 5.87 | |||||
| Price-to-Projected-FCF | 0.68 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.32 | |||||
| Price-to-Graham-Number | 0.85 | |||||
| Price-to-Net-Current-Asset-Value | 2.52 | |||||
| Price-to-Net-Cash | 4.82 | |||||
| Earnings Yield (Greenblatt) % | 24.63 | |||||
| FCF Yield % | 11.76 | |||||
| Forward Rate of Return (Yacktman) % | 28.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mizuho Medy Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 11,340.735 | ||
| EPS (TTM) (円) | 209.914 | ||
| Beta | 0.64 | ||
| Volatility % | 43.38 | ||
| 14-Day RSI | 44.67 | ||
| 14-Day ATR (円) | 28.858824 | ||
| 20-Day SMA (円) | 1686.475 | ||
| 12-1 Month Momentum % | 66.19 | ||
| 52-Week Range (円) | 1005 - 1945 | ||
| Shares Outstanding (Mil) | 19.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mizuho Medy Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mizuho Medy Co Ltd Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mizuho Medy Co Ltd Frequently Asked Questions
What is Mizuho Medy Co Ltd(TSE:4595)'s stock price today?
The current price of TSE:4595 is 円1661.00. The 52 week high of TSE:4595 is 円1945.00 and 52 week low is 円1005.00.
When is next earnings date of Mizuho Medy Co Ltd(TSE:4595)?
The next earnings date of Mizuho Medy Co Ltd(TSE:4595) is .
Does Mizuho Medy Co Ltd(TSE:4595) pay dividends? If so, how much?
The Dividend Yield %  of Mizuho Medy Co Ltd(TSE:4595) is 4.82% (As of Today), Highest Dividend Payout Ratio of Mizuho Medy Co Ltd(TSE:4595) was 0.33. The lowest was 0.17. And the median was 0.3. The  Forward Dividend Yield % of Mizuho Medy Co Ltd(TSE:4595) is 4.82%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers